Home › Funds › EcoR1 Capital, LLC › ZBIO
EcoR1 Capital, LLC position in ZBIO
ZENAS BIOPHARMA INC COM · Health Care
EcoR1 Capital, LLC reported holding 789,500 shares of ZBIO (ZENAS BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$20.0M, representing 1.03% of its reported portfolio and ranking #16 among its reported holdings. EcoR1 Capital, LLC has disclosed ZBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How EcoR1 Capital, LLC's ZBIO position evolved
EcoR1 Capital, LLC first disclosed a stake in ZBIO in Q4 2025 at 789,500 shares (US$28.7M). Across 3 filings, EcoR1 Capital, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 789,500 shares valued at US$20.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 789.50K | $28.67M | New |
| Q1 2026 | 789.50K | $15.43M | Hold |
| Q2 2026 | 789.50K | $20.04M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZBIO and 13F data
ZBIO (ZENAS BIOPHARMA INC COM) is a Health Care company. 68 other funds we track also report a position in ZBIO — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$127.9M), NEA Management Company, LLC (US$102.1M), Enavate Sciences GP, LLC (US$99.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZBIO
- SR ONE CAPITAL MANAGEMENT, LP 5.04M sh · $127.86M · Q2 2026
- NEA Management Company, LLC 4.02M sh · $102.11M · Q2 2026
- Enavate Sciences GP, LLC 3.92M sh · $99.47M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 67.20M sh · $80.32M · Q2 2026
- Royalty Pharma Sub-Manager, LLC 2.39M sh · $60.61M · Q2 2026
- Fairmount Funds Management LLC 2.36M sh · $59.87M · Q2 2026
- NVP Associates, LLC 1.84M sh · $46.66M · Q2 2026
- Context Capital Management, LLC 35.80M sh · $42.60M · Q2 2026
- ArrowMark Colorado Holdings LLC 573.32K sh · $14.55M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 509.79K sh · $12.94M · Q2 2026
- Rock Springs Capital Management LP 502.08K sh · $12.74M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 490.77K sh · $12.46M · Q2 2026
More on EcoR1 Capital, LLC
FAQ
How long has EcoR1 Capital, LLC held ZBIO?
EcoR1 Capital, LLC has disclosed ZBIO holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is EcoR1 Capital, LLC's current position in ZBIO?
As of Q2 2026, EcoR1 Capital, LLC holds 789.50K shares of ZBIO (ZENAS BIOPHARMA INC COM), valued at $20.04M, representing 1.03% of its reported portfolio and ranking #16.
Has EcoR1 Capital, LLC been buying or selling ZBIO?
In the latest 13F filing (Q2 2026), EcoR1 Capital, LLC held unchanged its position in ZBIO.
Which other funds hold ZBIO?
Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, NEA Management Company, LLC, Enavate Sciences GP, LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.